22.09.2017
- Israeli generics giant Teva has completed its exit from the women’s health sector. On Sept. 18 it unloaded its contraception, fertility, menopause and osteoporosis products to CVC...
13.09.2017
- After a protracted search, Israeli generics giant Teva has appointed a new president and chief executive officer. Kåre Schultz will take over from interim CEO Yitzhak Peterburg at...
